Matches in DBpedia 2015-10 for { <http://dbpedia.org/resource/RG7314> ?p ?o }
Showing triples 1 to 37 of
37
with 100 triples per page.
- RG7314 abstract "RG7314 is a selective small molecule antagonist of the vasopressin V1A receptor which is under development by Roche for the treatment of autism. As of August 2014, it is in phase II clinical trials for this indication.".
- RG7314 wikiPageExternalLink 800035102.
- RG7314 wikiPageID "43448376".
- RG7314 wikiPageLength "2025".
- RG7314 wikiPageOutDegree "10".
- RG7314 wikiPageRevisionID "663899640".
- RG7314 wikiPageWikiLink Arginine_vasopressin_receptor_1A.
- RG7314 wikiPageWikiLink Autism.
- RG7314 wikiPageWikiLink Category:Hormonal_agents.
- RG7314 wikiPageWikiLink Category:Vasopressin_receptor_antagonists.
- RG7314 wikiPageWikiLink Clinical_trial.
- RG7314 wikiPageWikiLink Hoffmann-La_Roche.
- RG7314 wikiPageWikiLink Phases_of_clinical_research.
- RG7314 wikiPageWikiLink Receptor_antagonist.
- RG7314 wikiPageWikiLink SRX246.
- RG7314 wikiPageWikiLink Small_molecule.
- RG7314 wikiPageWikiLinkText "RG7314".
- RG7314 hasPhotoCollection RG7314.
- RG7314 wikiPageUsesTemplate Template:Drugbox.
- RG7314 wikiPageUsesTemplate Template:Nervous-system-drug-stub.
- RG7314 wikiPageUsesTemplate Template:Neuropeptidergics.
- RG7314 wikiPageUsesTemplate Template:Reflist.
- RG7314 subject Category:Hormonal_agents.
- RG7314 subject Category:Vasopressin_receptor_antagonists.
- RG7314 hypernym Antagonist.
- RG7314 type ChemicalSubstance.
- RG7314 type Drug.
- RG7314 type ChemicalObject.
- RG7314 type Thing.
- RG7314 type Q8386.
- RG7314 comment "RG7314 is a selective small molecule antagonist of the vasopressin V1A receptor which is under development by Roche for the treatment of autism. As of August 2014, it is in phase II clinical trials for this indication.".
- RG7314 label "RG7314".
- RG7314 sameAs m.011jm1bc.
- RG7314 sameAs Q18392912.
- RG7314 sameAs Q18392912.
- RG7314 wasDerivedFrom RG7314?oldid=663899640.
- RG7314 isPrimaryTopicOf RG7314.